Semax vs Selank: Comparing Two Regulatory Neuropeptides

Two Russian-Developed Regulatory Neuropeptides

Semax and Selank are frequently studied side by side in the neuropeptide research literature, and for good reason: they share a common design philosophy while targeting distinct branches of central nervous system signaling. Both are short synthetic regulatory peptides developed in Russia, where a dedicated research tradition produced a family of stabilized fragment analogs intended to retain the activity of larger endogenous molecules while resisting rapid enzymatic breakdown. Understanding how the two compounds relate begins with recognizing what they have in common as a class.

Each compound is a heptapeptide built around a biologically active parent sequence that has been extended with a C-terminal Pro-Gly-Pro tripeptide. This same stabilizing motif appears in both molecules and is the structural signature of this Russian regulatory-peptide lineage. The motif slows peptidase-mediated degradation, which is what made these otherwise short-lived sequences practical as sustained research tools. Because they share this scaffold strategy, are both reported to be blood-brain-barrier permeable in research models, and are both studied for cognition-related endpoints, the two are often examined as complementary instruments rather than interchangeable ones — a point this comparison develops throughout.

Semax: An ACTH(4-10)-Derived Heptapeptide

Semax is a synthetic heptapeptide whose sequence — Met-Glu-His-Phe-Pro-Gly-Pro — is built on the ACTH(4-10) fragment of adrenocorticotropic hormone (ACTH), extended with the C-terminal Pro-Gly-Pro tripeptide. It is the more "neurotrophic" of the two compounds in terms of the mechanisms most emphasized in its literature.

Origin and Structural Basis

ACTH is a 39-amino-acid hormone classically associated with cortisol release via the MC2R receptor. Decades of research established that its ACTH(4-10) fragment carries neurotropic and behavioral activity that is separable from ACTH's steroidogenic role. The native fragment, however, is rapidly degraded by peptidases. Appending Pro-Gly-Pro to the C-terminus substantially slows this breakdown while preserving the neurotropic core, which is what enabled Semax to serve as a durable research compound rather than a fleeting one.

Mechanism Emphasis

The Semax research literature centers on neurotrophic and monoaminergic themes:

• BDNF and neurotrophic signaling: A central theme is Semax's association with brain-derived neurotrophic factor (BDNF) and its receptor TrkB. Cell-model and preclinical studies have reported increased expression of BDNF and related neurotrophins in hippocampal and other neuronal systems, frequently cited as a primary candidate mechanism.
• Dopaminergic and serotonergic modulation: Research has examined Semax's associations with monoaminergic neurotransmitter systems, including dopaminergic and serotonergic signaling, in laboratory models.
• Melanocortin interaction: As an ACTH-derived peptide, Semax retains partial-agonist interaction with certain melanocortin receptors, engaging the neuromodulatory arm of melanocortin signaling without strong steroidogenic activity at MC2R.
• Neuroprotection: Neuronal-culture and preclinical models have been used to study Semax in relation to neuronal survival, neurite outgrowth, and markers of oxidative stress and neuroinflammation.

Selank: A Tuftsin-Derived Heptapeptide

Selank is likewise a synthetic heptapeptide stabilized with a C-terminal Pro-Gly-Pro extension, but its parent sequence comes from an entirely different biological source: the immunomodulatory tetrapeptide tuftsin. This different origin is what gives Selank a mechanistic emphasis distinct from Semax.

Origin and Structural Basis

Tuftsin is a naturally occurring tetrapeptide (Thr-Lys-Pro-Arg) derived from the heavy chain of immunoglobulin G and is associated with immunomodulatory activity. Selank is an analog of tuftsin extended with the Pro-Gly-Pro tripeptide, yielding a heptapeptide that retains tuftsin-related activity while gaining the metabolic stability characteristic of this peptide family. As with Semax, the Pro-Gly-Pro motif is what converts a short-lived parent sequence into a practical research compound.

Mechanism Emphasis

Selank research emphasizes neurotransmitter-system and immune themes:

• GABAergic and serotonergic signaling: A prominent line of Selank research examines its associations with GABAergic signaling and serotonergic systems, studied in the context of anxiolytic-related neuromodulation in laboratory models.
• Enkephalinase inhibition: Selank has been studied for inhibition of enkephalin-degrading enzymes (enkephalinases), which can modulate the activity of endogenous regulatory peptides in research systems.
• BDNF expression: Like Semax, Selank has been examined in relation to BDNF expression, providing a point of mechanistic overlap between the two compounds.
• Immune and cytokine effects: Reflecting its tuftsin lineage, Selank is studied for immunomodulatory and cytokine-related effects, an axis largely absent from the Semax literature.

Head-to-Head: Origin, Mechanism, and Research Models

The clearest way to compare the two compounds is along three axes — where each peptide's parent sequence comes from, which signaling branches its research emphasizes, and the model systems in which it is typically studied.

Where the Literature Overlaps

The two compounds converge on several points. Both are Pro-Gly-Pro-stabilized heptapeptides from the same Russian regulatory-peptide tradition, both are reported as blood-brain-barrier permeable in research models, and both are studied for cognition-related endpoints. Importantly, BDNF appears in both literatures, so neurotrophic signaling is a genuine area of mechanistic overlap rather than a feature exclusive to Semax.

Where the Literature Diverges

The divergence follows directly from parentage. Semax's ACTH lineage anchors it in neurotrophic and monoaminergic neuroprotection research, with melanocortin-system interaction as a distinctive feature. Selank's tuftsin lineage anchors it in GABAergic/serotonergic anxiolytic-related signaling and in immune and cytokine effects — an immunomodulatory dimension that has no close counterpart in the Semax literature. In practice, researchers studying neurotrophic or neuroprotective endpoints more often reach for Semax, while those studying GABAergic neuromodulation or immune-linked signaling more often reach for Selank.

Selecting Between the Two for Research

Because the compounds differ in their mechanistic emphasis, the appropriate choice follows from the signaling question being asked rather than from any notion of one being "stronger" than the other.

• Match compound to pathway of interest: A GABAergic or enkephalinase-focused question is better served by Selank; a melanocortin or dopaminergic question is better served by Semax. BDNF-focused work can be approached with either, and the two are sometimes compared directly on this shared endpoint.
• Confirm the model expresses relevant targets: An immune/cytokine readout requires a model system in which those pathways are present — relevant to Selank's tuftsin-derived activity — while neurotrophic readouts depend on neuronal models expressing the appropriate neurotrophin machinery.
• Account for multi-target activity: Both peptides engage multiple pathways, so attributing a single readout to one mechanism requires careful experimental design and appropriate controls.
• Handle as peptides: Although both are more stable than their native parent sequences, they remain peptides and require appropriate handling to preserve integrity in research use.

Research Considerations and Limitations

• Concentrated literature base: Much of the foundational research on both compounds originates from a limited set of Russian and Eastern European research groups, and the body of work benefits from independent replication across additional laboratories.
• Literature accessibility: A substantial portion of the primary literature is published in Russian-language journals, which can complicate independent review and meta-analysis.
• Multi-target activity: Each peptide engages several pathways (BDNF/TrkB and monoamines for Semax; GABAergic/serotonergic, enkephalinase, and immune signaling for Selank), so single-mechanism attribution requires careful design.
• Model dependence: Findings derive predominantly from cell and rodent models; readouts in these systems do not translate directly to humans and inform research hypotheses only.
• Association vs. mechanism: Many comparative observations are associative; appropriate vehicle and target-specific controls remain essential to attribute an effect to a defined interaction.

Summary

Semax and Selank are two Pro-Gly-Pro-stabilized heptapeptides from the same Russian regulatory-peptide tradition, frequently studied side by side yet anchored in different biology by their parent sequences. Semax, derived from the ACTH(4-10) fragment, emphasizes neurotrophic/BDNF signaling, dopaminergic and serotonergic modulation, melanocortin interaction, and neuroprotection in neuronal models. Selank, derived from the immunomodulatory tetrapeptide tuftsin, emphasizes GABAergic and serotonergic anxiolytic-related signaling, enkephalinase inhibition, BDNF expression, and immune/cytokine effects. The two overlap on BDNF and on blood-brain-barrier-permeable, cognition-related study contexts, but diverge sharply in their monoaminergic-neuroprotective versus GABAergic-immunomodulatory emphases. Researchers studying neuromodulatory peptides alongside sleep- and recovery-related signaling sometimes also examine DSIP, a separate neuromodulatory peptide, when surveying how distinct regulatory-peptide systems are characterized in cell models. Across the comparison, the right choice depends on matching compound, mechanism, and model system to the specific signaling question.

Related Research

• Semax Research: ACTH-Derived Neuropeptide and Cognitive Function
• Selank Research: Tuftsin-Derived Peptide and GABAergic Signaling
• DSIP Research: Delta Sleep-Inducing Peptide and Neuromodulation